These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial. Gerard JP; Barbet N; Schiappa R; Magné N; Martel I; Mineur L; Deberne M; Zilli T; Dhadda A; Myint AS; Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):356-367. PubMed ID: 36801007 [TBL] [Abstract][Full Text] [Related]
5. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Burbach JP; den Harder AM; Intven M; van Vulpen M; Verkooijen HM; Reerink O Radiother Oncol; 2014 Oct; 113(1):1-9. PubMed ID: 25281582 [TBL] [Abstract][Full Text] [Related]
6. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer. Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419 [TBL] [Abstract][Full Text] [Related]
7. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521 [TBL] [Abstract][Full Text] [Related]
8. Acute Toxicity and Tumor Response in Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy With Shortening of the Overall Treatment Time Using Intensity-Modulated Radiation Therapy With Simultaneous Integrated Boost: A Phase 2 Trial. But-Hadzic J; Anderluh F; Brecelj E; Edhemovic I; Secerov-Ermenc A; Hudej R; Jeromen A; Kozelj M; Krebs B; Oblak I; Omejc M; Vogrin A; Velenik V Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1003-1010. PubMed ID: 27727065 [TBL] [Abstract][Full Text] [Related]
9. Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study. Lupattelli M; Matrone F; Gambacorta MA; Osti M; Macchia G; Palazzari E; Nicosia L; Navarria F; Chiloiro G; Valentini V; Aristei C; De Paoli A Radiat Oncol; 2017 Aug; 12(1):139. PubMed ID: 28830475 [TBL] [Abstract][Full Text] [Related]
10. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J; BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495 [TBL] [Abstract][Full Text] [Related]
11. A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer. Yang Y; Feng L; Wang Y; Ge R; Gong H; Xie C; Wang J; Chen J; Lan Y; Ma L Technol Cancer Res Treat; 2015 Oct; 14(5):557-63. PubMed ID: 24988052 [TBL] [Abstract][Full Text] [Related]
12. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610 [TBL] [Abstract][Full Text] [Related]
13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
14. Impact of Dose-Escalated Chemoradiation on Quality of Life in Patients With Locally Advanced Rectal Cancer: 2-Year Follow-Up of the Randomized RECTAL-BOOST Trial. Verweij ME; Hoendervangers S; Couwenberg AM; Burbach JPM; Berbee M; Buijsen J; Roodhart J; Reerink O; Pronk A; Consten ECJ; Smits AB; Heikens JT; van Grevenstein WHMU; Intven MPW; Verkooijen HLM Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):694-703. PubMed ID: 34634436 [TBL] [Abstract][Full Text] [Related]
15. A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. Salazar R; Capdevila J; Laquente B; Manzano JL; Pericay C; Villacampa MM; López C; Losa F; Safont MJ; Gómez A; Alonso V; Escudero P; Gallego J; Sastre J; Grávalos C; Biondo S; Palacios A; Aranda E BMC Cancer; 2015 Feb; 15():60. PubMed ID: 25886378 [TBL] [Abstract][Full Text] [Related]
16. Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer. Dizdarevic E; Frøstrup Hansen T; Pløen J; Henrik Jensen L; Lindebjerg J; Rafaelsen S; Jakobsen A; Appelt A Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):556-563. PubMed ID: 31707122 [TBL] [Abstract][Full Text] [Related]
17. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer. Yang Y; Liu Q; Jia B; Du X; Dai G; Liu H; Chen J; Zeng M; Wen K; Zhu Y; Wang Y; Feng L Technol Cancer Res Treat; 2019 Jan; 18():1533033818824367. PubMed ID: 30803368 [TBL] [Abstract][Full Text] [Related]
18. Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. Engineer R; Mohandas KM; Shukla PJ; Shrikhande SV; Mahantshetty U; Chopra S; Goel M; Mehta S; Patil P; Ramadwar M; Deodhar K; Arya S; Shrivastava SK Int J Colorectal Dis; 2013 Jul; 28(7):959-66. PubMed ID: 23358929 [TBL] [Abstract][Full Text] [Related]
19. Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study. Lupattelli M; Palazzari E; Polesel J; Chiloiro G; Angelicone I; Panni V; Caravatta L; Di Biase S; Macchia G; Niespolo RM; Franco P; Epifani V; Meldolesi E; de Giacomo F; Lucarelli M; Montesi G; Mantello G; Innocente R; Osti MF; Gambacorta MA; Aristei C; De Paoli A Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067405 [TBL] [Abstract][Full Text] [Related]